Loading...
Market
Which major pharmaceutical company will be most impacted by the Medicare drug price cuts by the end of 2024?
2
Resolution / Starting Odds
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Official announcements from the U.S. Department of Health and Human Services or the Centers for Medicare & Medicaid Services
Story
Biden Administration Announces $6 Billion Savings with Medicare Drug Price Cuts for 10 Drugs
Aug 15, 2024, 10:44 AM
The Biden administration has announced a landmark agreement to lower the prices of 10 of Medicare's most expensive and frequently used drugs. This move, part of the Inflation Reduction Act, is expected to save the U.S. government $6 billion and Medicare enrollees $1.5 billion in 2026. The negotiations, which involved major pharmaceutical companies, aim to reduce the annual $50 billion cost of these drugs. The new prices will take effect in 2026, marking the first time the federal government has directly negotiated drug prices with manufacturers. The administration projects a total savings of $7.5 billion, achieving a 22% reduction in costs.
View original story
Similar markets
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck & Co. • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
CVS • 25%
UNH • 25%
CI • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Yes • 50%
No • 50%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%